ArticleBMC gastroenterology2025

Neoadjuvant combination immunotherapy for colorectal cancer: clinical and molecular predictors of pathological complete response and safety assessment.

Yuegang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.